LB 481 – NebraskaStatus: Enacted
Year Introduced: 2017
PROVIDE FOR DRUG PRODUCT SELECTION FOR INTERCHANGEABLE BIOLOGICAL PRODUCTS: LB481 updates Nebraska Statutes to allow for the substitution of biologic products only with FDA approved interchangeable biologics. Current state law governs the substitution by pharmacists of generic drugs for their branded counterparts, and similar statutory direction is needed to construct state policy allowing for the substitution of FDA approved interchangeable biologics.
Return to Database Search
© 2018-2019 The SLIHCQ Database. Initial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.